Top Markets
#1 Islamic Coin Islamic Coin +151.49%
#2 Akedo Akedo +48.65%
#3 DOVU DOVU +48.14%
#4 Velvet Velvet +43.34%
#5 Black Phoenix Black Phoenix +33.95%
#6 Cross Cross +24.30%
#7 Cap Cap +20.40%
#8 DoubleZero DoubleZero +15.97%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.98%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +9.29%
Coin of the day
Islamic Coin Islamic Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Actavia Life Sciences, Inc. Actavia Life Sciences, Inc.

Actavia Life Sciences, Inc.

RASP
Rangering i aksjer #39683
Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing... Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.
Aksjekurs
$0.0005
Sist synkronisert: 2026-08-12
Markedsverdi
$385.91K
Endring (1 dag)
0.00%
Endring (1 år)
-87.50%
Land
US
Handel Actavia Life Sciences, Inc. (RASP)

Kategori

Healthcare
P/B-forhold for Actavia Life Sciences, Inc. (RASP)
P/B-forhold per 2026 TTM: 0
Ifølge Actavia Life Sciences, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Actavia Life Sciences, Inc. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE